Welcome to our
Media library

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…


Advanced search


PIE SOLS symposium 2022 12 min

Experts Layout Guidelines for Subthreshold Laser Treatment

Many countries are unable to afford continuous unending intravitreal injections for macular diseases,” said Dr. Kenneth Fong. Building the case for the use of subthreshold laser (STL) treatment and its application for retinal diseases, Dr. Fong and two other vitreoretinal doctors presented at a symposium on behalf of The Subthreshold Ophthalmic Laser Society (SOLS) at the recently held CAKE & PIE Expo 2.0 in Da Nang, Vietnam.
Subthreshold laser therapy guidelines for retinal diseases

Subthreshold laser therapy guidelines for retinal diseases

Subthreshold laser therapy has been utilised in clinical practice for more than three decades, and numerous randomised and real-life studies has proven its efficacy and safety in various retinal diseases. However, despite decades of usage, we still do not have a standard protocol for subthreshold laser applications and settings.
Play button

Subthreshold laser: a new hope for macular degeneration?

Dr Lihteh Wu presents why Subthreshold laser can be consider as a new hope for macular degeneration.
Dr Fong EURETINA 2022
Play button

Best practices in subthreshold laser treatment, which laser should be used and how?

Dr Kenneth Fong presents best practices in subthreshold laser treatment to easily understand which laser should be used and how.
Dr Filloy EURTINA 2022
Play button

Central Serous Chorioretinopathy: effectiveness and safety without verteporfin?

During 2022 EURETINA congress, Dr Alejandro Filloy explains how to treat CSC safely and effectively without verteporfin.
Victor Chong EURETINA 2022
Play button

Retinal laser treatments in Covid 19 era: from PDR to DME

During 2022 EURETINA symposium, Dr Victor Chong presents the use of retinal laser treatments in COVID 19 era, from PDR to DME.